المساهمون: Uludağ Üniversitesi/Sağlık Bilimleri Enstitüsü/Biyoistatistik Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Genetik Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Biyoistatistik Anabilim Dalı., orcid:0000-0002-2382-290X, Taş, Ezel Özge, Saǧ, Şebnem, Ercan, İlker, ABF-2367-2020, 57202504515, 36638231300, 6603789069

مصطلحات موضوعية: Oncology, Meta analysis, Polysomy 17, Breast cancer, HER2, Amplification, In-situ hybridization, Chromosome-17 polysomy, Gene amplification, Meta analiz, Polizomi 17, Meme kanseri, Amplifikasyon, Breast Neoplasms, Human ERBB2 Protein, Fluorescence In Situ Hybridization, Epidermal growth factor receptor 2, Estrogen receptor, Progesterone receptor, Article, Cancer prognosis, Gene, HER2 gene, Human, Immunohistochemistry, Lymph node metastasis, Mantel Haenszel test, Numerical chromosome aberration, Protein expression, Publishing

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi; Taş, E. Ö. vd. (2018). ''Investigating the impact of polysomy 17 in breast cancer patients without amplification through meta-analysis''. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, 28(2), 95-103.; https://www.webofscience.com/wos/woscc/full-record/WOS:000435383300004Test; https://hdl.handle.net/11452/39272Test; 000435383300004; 2-s2.0-85048596591; 95; 103; 28; https://doi.org/10.4999/uhod.182508Test

الإتاحة: https://doi.org/10.4999/uhod.182508Test
https://hdl.handle.net/11452/39272Test
https://www.webofscience.com/wos/woscc/full-record/WOS:000435383300004Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., orcid:0000-0002-7346-7440, Uğraş, Nesrin, Yerci, Ömer, Özgün, Gonca, Deligönül, Adem, Dündar, Halit Ziya, Sarkut, Pınar, Uludağ, Özkan Kanat, AAH-2716-2021, 55386535600, 6603810549, 35520074800, 37088030300, 55453773300, 55806454400, 57193505535

مصطلحات موضوعية: Gastroenterology & hepatology, CDX2, CK7, HER2, Immunohistochemistry, Periampullary adenocarcinoma, HER4, Ampullary cancer, Overexpression, Carcinoma, Pancreaticobiliary, Prognosis, Papilla, Differentiation, Oncogene, Diagnosis, Vater, Ampulla of Vater, Duodenal Neoplasms, Adenoma, Cytokeratin 7, Epidermal growth factor receptor 2, Epidermal growth factor receptor 4, Transcription factor Cdx2, Adult, Article, Bile duct carcinoma, Blood vessel, Cancer prognosis, Cancer staging

العلاقة: Makale - Uluslararası Hakemli Dergi; Acta Gastro-Enterologica Belgica; Uğraş, N. vd. (2017). ''Immunohistochemical expression of CDX2, CK7, HER2 and HER4 in periampullary adenocarcinoma: Implications for clinicopathology and patient outcomes''. Acta Gastro-Enterologica Belgica, 80(1), 31-37.; http://hdl.handle.net/11452/33550Test; 000403607000006; 2-s2.0-85014317564; 31; 37; 80

الإتاحة: http://hdl.handle.net/11452/33550Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., orcid:0000-0002-7346-7440, Uğraş, Nesrin, Yerci, Ömer, Özgün, Gonca, Deligönül, Adem, Dündar, Halit Ziya, Sarkut, Pınar, Uludağ, Özkan Kanat, AAH-2716-2021, 55386535600, 6603810549, 35520074800, 37088030300, 55453773300, 55806454400, 57193505535

مصطلحات موضوعية: Gastroenterology & hepatology, CDX2, CK7, HER2, Immunohistochemistry, Periampullary adenocarcinoma, HER4, Ampullary cancer, Overexpression, Carcinoma, Pancreaticobiliary, Prognosis, Papilla, Differentiation, Oncogene, Diagnosis, Vater, Ampulla of Vater, Duodenal Neoplasms, Adenoma, Cytokeratin 7, Epidermal growth factor receptor 2, Epidermal growth factor receptor 4, Transcription factor Cdx2, Adult, Article, Bile duct carcinoma, Blood vessel, Cancer prognosis, Cancer staging

العلاقة: Makale - Uluslararası Hakemli Dergi; Acta Gastro-Enterologica Belgica; Uğraş, N. vd. (2017). ''Immunohistochemical expression of CDX2, CK7, HER2 and HER4 in periampullary adenocarcinoma: Implications for clinicopathology and patient outcomes''. Acta Gastro-Enterologica Belgica, 80(1), 31-37.; http://hdl.handle.net/11452/33550Test; 000403607000006; 2-s2.0-85014317564; 31; 37; 80

الإتاحة: http://hdl.handle.net/11452/33550Test

المؤلفون: Ulaş, Arife

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Tıbbi Onkoloji Bilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı., orcid:0000-0003-1094-5772, orcid:0000-0002-3669-6391, orcid:0000-0002-9038-0515, orcid:0000-0002-0070-0889, orcid:0000-0001-7934-7039, orcid:0000-0002-5446-1254, orcid:0000-0002-9732-5340, Avci, Nilufer, Deligonul, Adem, Tolunay, Sahsine, Cubukcu, Erdem, Olmez, Omer Fatih, Hartavi, Mustafa, Kurt, Ender, Evrensel, Turkkan, CCT-7946-2022, ESM-4544-2022, AAI-1612-2021, ETP-1691-2022, DJG-4827-2022, CUI-5353-2022, DAS-3088-2022, AAJ-1027-2021, 55390409800, 37088030300, 6602604390, 53986153800, 26435400000, 55370753300, 7006207332, 6603942124

مصطلحات موضوعية: Breast cancer, Estrogen/progesterone receptor, HER2, Immunohistochemistry, Ki-67, Neoadjuvant chemotherapy, KI67, Oncology, Adult, Anthracyclines, Antineoplastic combined chemotherapy protocols, Breast neoplasms, Chemotherapy, adjuvant, Disease-Free survival, Female, Humans, Ki-67 antigen, Middle aged, Neoadjuvant therapy, Neoplasm grading, Predictive value of tests, Prospective studies, Receptor, ErbB-2, Receptors, estrogen, progesterone, Survival analysis, Taxoids

العلاقة: Makale - Uluslararası Hakemli Dergi; Journal of B.U.ON.; Yurt içi; Sanayi; Avci, N. vd. (2015). "Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer". Journal of B.U.ON., 20(1), 45-49.; https://doi.orgTest/; http://hdl.handle.net/11452/34180Test; 000351566500007; 2-s2.0-84928700466; 45; 49; 20

الإتاحة: http://hdl.handle.net/11452/34180Test

المؤلفون: Ulaş, Arife

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Tıbbi Onkoloji Bilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı., orcid:0000-0003-1094-5772, orcid:0000-0002-3669-6391, orcid:0000-0002-9038-0515, orcid:0000-0002-0070-0889, orcid:0000-0001-7934-7039, orcid:0000-0002-5446-1254, orcid:0000-0002-9732-5340, Avci, Nilufer, Deligonul, Adem, Tolunay, Sahsine, Cubukcu, Erdem, Olmez, Omer Fatih, Hartavi, Mustafa, Kurt, Ender, Evrensel, Turkkan, CCT-7946-2022, ESM-4544-2022, AAI-1612-2021, ETP-1691-2022, DJG-4827-2022, CUI-5353-2022, DAS-3088-2022, AAJ-1027-2021, 55390409800, 37088030300, 6602604390, 53986153800, 26435400000, 55370753300, 7006207332, 6603942124

مصطلحات موضوعية: Breast cancer, Estrogen/progesterone receptor, HER2, Immunohistochemistry, Ki-67, Neoadjuvant chemotherapy, KI67, Oncology, Adult, Anthracyclines, Antineoplastic combined chemotherapy protocols, Breast neoplasms, Chemotherapy, adjuvant, Disease-Free survival, Female, Humans, Ki-67 antigen, Middle aged, Neoadjuvant therapy, Neoplasm grading, Predictive value of tests, Prospective studies, Receptor, ErbB-2, Receptors, estrogen, progesterone, Survival analysis, Taxoids

العلاقة: Makale - Uluslararası Hakemli Dergi; Journal of B.U.ON.; Yurt içi; Sanayi; Avci, N. vd. (2015). "Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer". Journal of B.U.ON., 20(1), 45-49.; https://doi.orgTest/; http://hdl.handle.net/11452/34180Test; 000351566500007; 2-s2.0-84928700466; 45; 49; 20

الإتاحة: http://hdl.handle.net/11452/34180Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., orcid:0000-0002-9732-5340, Bayrak, Mehmet, Ölmez, Ömer Fatih, Kurt, Ender, Çubukçu, Erdem, Evrensel, Türkkan, Kanat, Özkan, Manavoǧlu, Osman, AAJ-1027-2021, 57210190959, 26435400000, 7006207332, 53986153800, 6603942124, 55881548500, 6602587152

مصطلحات موضوعية: Oncology, C-erbB2, Gastric cancer, Metastasis, Immunohistochemistry, Prognosis, Expression, Trastuzumab, Breast, Her2, Adult, Aged, Female, Humans, Male, Middle aged, Neoplasm metastasis, Receptor, erbB-2, Stomach neoplasms, Survival analysis, Tumor markers, biological, Up-regulation, Young adult, Cancer, Gastroesophageal Junction, Epidermal growth factor receptor 2, Article, C erbB2 gene

العلاقة: Makale - Uluslararası Hakemli Dergi; Clinical and Translational Oncology; Bayrak, M. vd. (2013). "Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer". Clinical and Translational Oncology, 15(4), 307-312.; https://doi.org/10.1007/s12094-012-0921-0Test; https://link.springer.com/article/10.1007/s12094-012-0921-0Test; http://hdl.handle.net/11452/29523Test; 000316260600009; 2-s2.0-84876494901; 307; 312; 15

الإتاحة: https://doi.org/10.1007/s12094-012-0921-0Test
http://hdl.handle.net/11452/29523Test